Comparison of different methods of morphine inhalation in dyspnoea and cough;Porównanie sposobów inhalacji morfiny podawanej w duszności i kaszlu

Polska Medycyna Paliatywna

Volumn 5, Issue 4, 2006, Pages 145-153

  Krajnik, Małgorzata ^a   Podolec, Zygmunt ^b  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b Centrum Badawczo Rozwojowe abcMED W Krakowie   (Poland)

Author keywords

Aerosol particle; Inhalation; Morphine; Pneumodosimeter

Indexed keywords

MORPHINE; OPIATE RECEPTOR;

AEROSOL; ARTICLE; BRONCHUS MUCOSA; COUGHING; DYSPNEA; INTERMETHOD COMPARISON; LUNG ALVEOLUS; PARTICLE SIZE; RESPIRATORY SYSTEM; SIMULATION;

EID: 33947311885     PISSN: 1644115X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Krajnik M., Zylicz Z., Adamczyk A. Jak działaja̧ opioidy w duszności? Polska Medycyna Paliatywna 2003; 2: 183-190.
2. Peiffer C., Poline J.B., Thivard L., Aubier M., Samson Y. Neural substrates for the perception of acutely induced dyspnea. Am. J. Respir. Crit. Care Med. 2001; 163: 951-957.
3. Jennings A.L., Davis A.N., Higgins J.P., Gibbs J.S., Broadley K.E. A systematic review of the use of opioids in the management of dyspnoea. Thorax 2002; 57: 939-944.
4. Bruera E., Sala R., Spruyt O., Palmer J.L., Zhang T., Willey J. Nebulized versus subcutaneous morphine for patients with cancer dyspnea: a preliminary study. J. Pain Symptom Manage 2005; 29: 613-618.
5. Brown S.J., Eichner S.F., Jones J.R. Nebulized morphine for relief of dyspnea due to chronic lung disease. Ann. Pharmacother. 2005; 39: 1088-1092.
6. Otulana B., Okinawa J., Linn L., Morishige R., Thipphawong J. Safety and pharmacokinetics of inhaled morphine delivered using the AERx system in patients with moderate-to-severe asthma. Int. J. Clin. Pharmacol. Ther. 2004; 42: 456-462.
7. Ray N.J., Jones A.J., Keen P. Morphine, but not sodium cromoglycate, modulates the release of substance P from capsaicin-sensitive neurones in the rat trachea in vitro. Br. J. Pharmacol. 1991; 102: 797-800.
8. Auberson S., Lacroix J.S., Kordestani R.K., Lundberg J.M. Prejunctional control of pH 6-induced bronchoconstriction by NK1, NK2, μ-opioid, α2-adrenoceptor and glucocorticoid receptors in guinea-pig isolated perfused lung. J. Pharm. Pharmacol. 1998; 50: 899-905.
9. Lindström E.G., Andersson R.G.G. Morphine modulates contractile responses and neurokinin A-Ll release elicited by electrical field stimulation or capsaicin in a guinea pig bronchial-tube preparation. Am. J. Respir. Crit. Care Med. 1995; 151: 1175-1179.
10. Belvisi M.G., Stretton C.D., Verleden G.M., Ledingham S.J., Yacoub M.H., Barnes P.J. Inhibition of cholinergic neurotransmission in human airways by opioids. J. Appl. Physiol. 1992; 72: 1096-1100.
11. Fischer A.B., Undem J. Naloxone blocks endomorphin-1 but not endomorphin-2 induced inhibition of tachykinergic contractions of guinea-pig isolated bronchus. Br. J. Pharmacol. 1999; 127: 605-608.
12. Rogers D.F., Barnes P.J. Opioid inhibition of neurally mediated mucus secretion in human bronchi. Lancet 1989; 1 (8644): 930-932.
13. Lei Y.H., Rogers D.F. Effects and interactions of opioids on plasma exudation induced by cigarette smoke in guinea pig bronchi. Am. J. Physiol. Lung Cell Mol. Physiol. 1999; 276: L391-L397.
14. Karlsson J.A., Lanner A.S., Persson C.G.A. Airway opioid receptors mediate inhibition of cough and reflex bronchoconstriction in guinea pigs. J. Pharmacol. Exper. Therap. 1990; 252: 863-868.
15. Cabot P.J., Cramond T., Smith M.T. Quantitative autoradiography of peripheral opioid binding sites in rat lung. Eur. J. Pharmacol. 1996; 310: 47-53.
16. Bhargava H.N., Villar V.M., Cortijo J., Morcillo E.J. Binding of [D-Ala2, MePhe4, Gly-ol5] enkephalin, [3H][D-Pen2, D-Pen5]enkephalin, and [3H]U-69,593 to airway and pulmonary tissues of normal and sensitized rats. Peptides 1997; 18: 1603-1608.
17. Cabot P.J., Dodd P.R., Cramond T., Smith M.T. Characterization of non-conventional opioid 9binding sites in rat and human lung. Eur. J. Pharmacol. 1994; 268: 247-255.
18. Sunday M.E., Haley K.J., Emanuel R.L. i wsp. Fetal alveolar epithelial cells contain [D-Ala2]-deltorphin I-like immunoreactivity. δ-and μ-opiate receptors mediate opposite effects in developing lung. Am. J. Respir. Cell Mol. Biol. 2001; 25: 447-456.
19. th World Congress on Pain, IASP Press, Seattle 2005: 419 (streszczenie).
20. Hurley P.K., Smye S.W., Cunliffe H. Assessment of antibiotic aerosol generation using commertial jet nebulizers. J. Aerosol. Med. 1994; 7: 217-228.
21. Finch S. How and why Nebulizer droplet size is measured. Inter. Tech. Buil. 1991; 1.
22. Lewis R.A., Fleming J.S. Fractional deposition from a jet nebulizer: how it differs from a meter dose inhaler. Br. J. Dis. Chest 1985; 79: 361-367.
23. Newman S.P., Pitcairn G.R., Hirst P.H., Rankin L. Radionuclide imaging technologies and their use In evaluating asthma drug depositiom in the lungs. Adv. Drug Deliv. Rev. 2003; 55: 851-867.
24. Miller R.F., Godfrey-Faussett P., Semple S.J. Nebulised pentamidine as treatment for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Thorax 1989; 44: 565-569.
25. Simonds A.K., Newman S.P., Johnson M.A., Talaee N., Lee C.A., Clarke S.W. Aerosolised pentamidine. Lancet 1989; 1 (8631): 221-222.
26. Hakkinen A.M., Uusi-Heikkila H., Jarvinen M., Saali K., Karhumaki L. The effect of breathing frequency on deposition of drug aerosol using an inhalation-synchronized dosimeter in healthy adults. Clin. Physiol. 1999; 1: 269-274.
27. Nieminen M.M., Holli H., Lahdensuo A., Muittari A., Karvonen J. Aerosol deposition in automatic dosimeter nebulization. Eur. J. Respir. Dis. 1987; 71: 145-152.
28. Podolec Z. Pneumodosimeter - the application of BCTS metod (Bronchial Control Treatment System) to breath-controlled application of medicine aerosols in water solutions to persons suffering from mucoviscidosis (http://www.ecfsoc. org/Vienna/nursing.htm).
29. Collis G.G., Cole C.H., Le Souef P.N. Dilution of nebulised aerosols by air entrainment in children. Lancet 1990; 11: 341-343.